Drug Discovery

All articles

Making sense of technology transfer download preview

Making Sense of2 min read

Making sense of technology transfer Read more

Image taken from complex chemistry at Sterling animation

Animation2 min read

Complex chemistry at Sterling Read more

Preview image of the complex molecules, complex chemistry whitepaper

Whitepaper9 min read

The rise of complex chemistry in small molecule API development Read more

Making Sense of4 min read

Making sense of Partnership Management

The importance of collaboration and transparency in an outsourced pharmaceutical manufacturing partner.

Read more

Mathew Minardi, EVP of Global Project Management at Sterling and webinar's presenter

Webinar1 min read

Setting the foundation for success: Streamlining early phase API discovery and development Read more

Cary carousel

Article2 min read

Sterling Pharma Solutions expands early phase development capabilities at Cary Read more

Making sense of controlled substances download preview

Making Sense of5 min read

Making sense of controlled substances

Navigating complex regulatory requirements with the right outsourced partner.

Read more

Image from early phase API discovery and development at Sterling animation showing scientists at work

Animation2 min read

Early phase API discovery and development Read more

Scientist in labs at Sterling performing early phase development work

Article8 min read

Top 10 early phase considerations Read more

Next Page »

Explore more

All ADCs API Development API Manufacturing Analytical Services Drug Discovery Facilities News PDMO People Peptides Sustainability Technologies

Sign up for updates

Be the first to see the latest articles and updates from industry leaders, delivered straight to your inbox

Comments

This field is for validation purposes and should be left unchanged.

Name(Required)

Email(Required)

Company Name(Required)

This field is hidden when viewing the form

Prospect Source

Please click here for our privacy policy

Service. Passion. Science.

PDMO^® is registered in the U.S. Patent and Trademark Office.

PDMO^® is a registered trademark of Sterling Pharma Solutions Limited (EUIPO and UKIPO). All rights reserved.

Sterling Pharma Solutions Limited. Registration number: 05712796. Registered office address: Dudley Lane, Dudley, Cramlington, NE23 7QG, United Kingdom. Registered in England.